Dyne Therapeutics (DYN) Earnings Date, Estimates & Call Transcripts $11.18 +0.41 (+3.76%) As of 03:46 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Dyne Therapeutics Earnings Summary Upcoming Earnings DateMay. 1Before Market OpensEstimatedConsensus EPS (Mar. 4) -$0.92 Actual EPS (Mar. 4) -$0.88 Beat By $0.04 Dyne Therapeutics released Q4 2024 earnings on March 4, 2025, reporting an EPS of -$0.88, which beat analysts' consensus estimates of -$0.92 by $0.04. With a trailing EPS of -$3.35, Dyne Therapeutics' earnings are expected to decrease next year, from ($3.44) to ($3.62) per share. Q4 2024 Earnings ResourcesQ4 2024 Earnings Report Press Release (8-K) Annual Report (10-K)DYN Upcoming EarningsDyne Therapeutics' Q1 2025 earnings is scheduled for Thursday, May 1, 2025, with a conference call scheduled on Friday, May 2, 2025 at 12:30 PM ET. Check back for transcripts, audio, and key financial metrics as they become available.Powered by Get Dyne Therapeutics Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Dyne Therapeutics and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataDYN Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter. Dyne Therapeutics Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20251-$0.90-$0.90-$0.90Q2 20251-$0.91-$0.91-$0.91Q3 20251-$0.91-$0.91-$0.91Q4 20251-$0.91-$0.91-$0.91FY 20254($3.63)($3.63)($3.63) Dyne Therapeutics Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails 5/1/2025(Estimated)--------3/4/2025Q4 2024-$0.92-$0.88+$0.04-$0.88--11/12/2024--$0.71-$0.96 -$0.25-$0.96--8/12/2024--$0.72-$0.70+$0.02-$0.70--5/2/2024Q1 2024-$0.81-$0.81--$0.81--3/5/2024Q4 2023-$0.92-$1.09 -$0.17-$1.09--10/30/2023Q3 2023-$0.83-$0.99 -$0.16-$0.99--8/3/2023Q2 2023-$0.81-$1.08 -$0.27-$1.08--5/11/2023Q1 2023-$0.77-$0.78 -$0.01-$0.78--5/11/2023Q1 2023-$0.77-$0.78 -$0.01-$0.78--5/11/2023Q1 2023-$0.77-$0.78 -$0.01-$0.78-- Get the Latest News and Ratings for DYN and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Dyne Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 5/11/2023Q1 2023-$0.77-$0.78 -$0.01-$0.78--5/11/2023Q1 2023-$0.77-$0.78 -$0.01-$0.78--5/11/2023Q1 2023-$0.77-$0.78 -$0.01-$0.78-- Dyne Therapeutics Earnings - Frequently Asked Questions When is Dyne Therapeutics's earnings date? Dyne Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, May 1st, 2025 based off last year's report dates. Learn more on DYN's earnings history. Did Dyne Therapeutics beat their earnings estimates last quarter? In the previous quarter, Dyne Therapeutics (NASDAQ:DYN) reported ($0.88) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.92) by $0.04. Learn more on analysts' earnings estimate vs. DYN's actual earnings. How much profit does Dyne Therapeutics generate each year? Dyne Therapeutics (NASDAQ:DYN) has a recorded net income of -$235.94 million. DYN has generated -$3.35 earnings per share over the last four quarters. What is Dyne Therapeutics's EPS forecast for next year? Dyne Therapeutics's earnings are expected to decrease from ($3.44) per share to ($3.62) per share in the next year. More Earnings Resources from MarketBeat Related Companies Elanco Animal Health Earnings Results Vaxcyte Earnings Results Rhythm Pharmaceuticals Earnings Results PTC Therapeutics Earnings Results Avidity Biosciences Earnings Results Arcellx Earnings Results Ultragenyx Pharmaceutical Earnings Results Zai Lab Earnings Results Akero Therapeutics Earnings Results Merus Earnings Results Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Seismic Shift at Intel: Massive Layoffs Precede Crucial EarningsRocket Lab Lands New Contract, Builds Momentum Ahead of EarningsAmazon's Earnings Could Fuel a Rapid Breakout Tesla Earnings Miss, But Musk Refocuses and Bulls ReactQualcomm’s Range Narrows Ahead of Earnings as Bulls Step InWhy It May Be Time to Buy CrowdStrike Stock Heading Into EarningsCan IBM’s Q1 Earnings Spark a Breakout for the Stock? This page (NASDAQ:DYN) was last updated on 4/24/2025 by MarketBeat.com Staff From Our PartnersFeds Just Admitted It—They Can Take Your CashHere’s the cold truth: If your money is sitting idle in a bank account, it’s vulnerable. That’s why thousan...Priority Gold | SponsoredTrump Orders 'National Digital Asset Stockpile'‘Digital Asset Reserve’ for THIS Coin??? Get all the details before this story gains even more tractionCrypto 101 Media | SponsoredJames Altucher: Do not invest in AI unless…I made millions during the crypto boom. Many “experts” are now saying… Artificial Intelligence opportuni...Paradigm Press | SponsoredThe Exact July Date the AI Correction Will End?AI stocks have cooled off—but Jeff Brown, the tech expert who picked Nvidia before it soared 222x, says one da...Brownstone Research | SponsoredThis Is The Moment You Betray Trump (Or Prove Them Wrong)They said you wouldn’t last—that Bidenflation, Wall Street selloffs, and DEI funds would break your loyalty to...Colonial Metals | SponsoredVirtually Limitless Energy?A radical energy breakthrough could change everything. Scientists at MIT and a stealth startup may have discov...Stansberry Research | SponsoredMusk’s real agenda in D.C. In this urgent exposé, you’ll discover… How Elon and Donald Trump are quietly drawing a radical new map of ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Dyne Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Dyne Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
